Aigen Investment Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,209
| Closed | -$191K | – | 921 |
|
|
2024
Q3 | $191K | Sell |
12,209
-22,980
| -65% | -$359K | 0.04% | 594 |
|
|
2024
Q2 | $603K | Buy |
35,189
+24,312
| +224% | +$416K | 0.12% | 249 |
|
|
2024
Q1 | $170K | Buy |
+10,877
| New | +$170K | 0.04% | 566 |
|
|
2023
Q4 | – | Sell |
-45,433
| Closed | -$734K | – | 987 |
|
|
2023
Q3 | $734K | Buy |
+45,433
| New | +$734K | 0.14% | 242 |
|
|
2021
Q4 | – | Sell |
-5,259
| Closed | -$611K | – | 1139 |
|
|
2021
Q3 | $611K | Buy |
+5,259
| New | +$611K | 0.12% | 218 |
|
|
2021
Q2 | – | Sell |
-1,690
| Closed | -$223K | – | 652 |
|
|
2021
Q1 | $223K | Buy |
+1,690
| New | +$223K | 0.03% | 513 |
|
|
2020
Q3 | – | Sell |
-19,774
| Closed | -$1.17M | – | 1032 |
|
|
2020
Q2 | $1.17M | Buy |
19,774
+6,999
| +55% | +$415K | 0.15% | 210 |
|
|
2020
Q1 | $860K | Sell |
12,775
-9,616
| -43% | -$647K | 0.11% | 253 |
|
|
2019
Q4 | $1.89M | Buy |
+22,391
| New | +$1.89M | 0.31% | 72 |
|